Skip to main content
Clinical Trials/JPRN-UMIN000018626
JPRN-UMIN000018626
Completed
Phase 2

Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty using Titanium Bridges - Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty using Titanium Bridges

Kumamoto University0 sites20 target enrollmentAugust 10, 2015

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Adductor Spasmodic Dysphonia
Sponsor
Kumamoto University
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2015
End Date
March 29, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Dysphagia, laryngeal paralysis, or any structural disorder in the vocal cord 2\. Previous surgery for adductor spasmodic dysphonia 3\. Local injection of botulinum toxin type A into the intralaryngeal muscles within 6 months before informed consent 4\. Serious concomitant diseases 5\. Surgery with general anesthesia scheduled during the study period or surgery performed within the past 4 weeks 6\. Participation in any other study using any other intervention within 12 weeks before informed consent, or planned participation in such a study during the study period after enrollment in this study 7\. Psychiatric disorder requiring treatment, or mental or intellectual disability that may affect the conduct of the study 8\. A history of alcoholism or drug abuse 9\. A history of hypersensitivity to pure titanium 10\. Women who are pregnant or planning to become pregnant during the study period 11\. Patients deemed ineligible for this study by the investigator for any other reason

Outcomes

Primary Outcomes

Not specified

Similar Trials